EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Therapeutic Use of Psilocybin in Depression: a Systematic Review of Clinical Evidence

Filipe Reis Teodoro Andrade iD, Tobias Buchborn, Gabriel Thalheimer, Marcus W Meinhardt, Samia Joca, Rosa Maria Martins de Almeida

Acta Neuropsychiatrica · 2025

DOI: 10.1017/neu.2025.10039 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Acta Neuropsychiatrica, 2025. Verfasst von Filipe Reis Teodoro Andrade und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychopharmacology, Central Institute of Mental Health (ZI), Mannheim, Germany. Hauptthemen laut MEDLINE: Psilocybin, Major Depressive Disorder, Hallucinogens, Antidepressive Agents. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Major depressive disorder (MDD) is a significant public health concern, and current treatments often have limitations in effectiveness and adherence. Psilocybin, a psychedelic compound found in certain mushrooms, is being explored as a potential treatment for depression. It primarily acts through the serotonin 5-HT2A receptor but interacts with 5-HT1A and 5-HT2C receptors. Its precise mechanisms remain under investigation.

Objectives

(1) To consolidate evidence on psilocybin’s efficacy and safety for depression and the role of 5HT2a, (2) to identify limitations in the literature, and (3) to highlight areas needing further research.

Methods

This systematic review follows PRISMA guidelines and analyses 22 studies, including randomised controlled trials (RCTs) and open-label studies. The studies cover various populations, including individuals with treatment-resistant depression, different dosing regimens, and adjunctive therapies.

Results

Psilocybin therapy shows substantial and rapid antidepressant effects, often after one or two sessions with psychological support. Improvements are sustained for weeks or months in many cases. Psilocybin is generally well-tolerated, with mild adverse effects such as anxiety during administration and transient headaches, which are manageable in controlled settings.

Conclusions

Psilocybin demonstrates promise as a novel treatment for depression, especially for individuals unresponsive to conventional antidepressants. Further research is needed to refine dosing, explore long-term effects, and understand its mechanisms of action.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsilocybinMajor Depressive DisorderHallucinogensAntidepressive AgentsDepressive Disorder, Treatment-ResistantHumansTreatment OutcomeRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

5HT2a receptorDepressive DisorderPsilocybinPsychedelicsSystematic Review

Substanzen

PsilocybinHallucinogensAntidepressive Agents

Autor:innen und Institutionen

  • Department of Psychopharmacology, Central Institute of Mental Health (ZI), Mannheim, Germany.
  • Department of Developmental and Personality Psychology, Laboratory of Experimental Psychology, Neuroscience and Behavior (LPNeC), Universidade Federal of Rio Grande do Sul (UFRGS), Porto Alegre, Brazil.
  • Department of Biomedicine - Forskning og uddannelse, Vest, Aarhus University, Aarhus, Denmark.

ORCID-Profile: Filipe Reis Teodoro Andrade

Zitieren

APA

Andrade, F. R. T., Buchborn, T., Thalheimer, G., Meinhardt, M. W., Joca, S., & de Almeida, R. M. M. (2025). Therapeutic Use of Psilocybin in Depression: a Systematic Review of Clinical Evidence. Acta Neuropsychiatrica. https://doi.org/10.1017/neu.2025.10039

Vancouver

Andrade FRT, Buchborn T, Thalheimer G, Meinhardt MW, Joca S, de Almeida RMM. Therapeutic Use of Psilocybin in Depression: a Systematic Review of Clinical Evidence. Acta Neuropsychiatrica. 2025. doi:10.1017/neu.2025.10039

BibTeX
@article{Andrade2025,
  author = {Andrade, Filipe Reis Teodoro and Buchborn, Tobias and Thalheimer, Gabriel and Meinhardt, Marcus W and Joca, Samia and de Almeida, Rosa Maria Martins},
  title = {Therapeutic Use of Psilocybin in Depression: a Systematic Review of Clinical Evidence},
  journal = {Acta Neuropsychiatrica},
  year = {2025},
  doi = {10.1017/neu.2025.10039}
}
Kostenlos starten →